SCA Pharmaceuticals, LLC: Drug Recall
Recall #D-0398-2024 · 11/09/2023
Class II: Risk
Recall Details
- Recall Number
- D-0398-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- SCA Pharmaceuticals, LLC
- Status
- Terminated
- Date Initiated
- 11/09/2023
- Location
- Windsor, CT, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 613 Cassettes
Reason for Recall
Lack of Assurance of Sterility
Product Description
fentaNYL 200 mcg/100 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Injection, (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0231-64, Bar Code 70004023164
Distribution Pattern
Nationwide in the USA
Other Recalls by SCA Pharmaceuticals, LLC
- Class II: Risk 11/09/2023
- Class II: Risk 11/09/2023
- Class II: Risk 11/09/2023
- Class II: Risk 11/09/2023
- Class II: Risk 11/09/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.